RxDoctor Payments Data

Kristin Larson

Adult Health · Salt Lake City, UTNPI 1427166461

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $46,525 of the $74,872 with a category attached, or 62.1%. AstraZeneca accounts for 89.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $24,183 and has fallen 76.3% since, to $5,719 in 2025. Among adult health clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,872in general payments, 2019–2025

Across 190 payments — averaging $394.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$67K
  • Amgen$2K
  • GSK$2K
  • Vifor Pharma, Inc.$943
  • Ardelyx, Inc.$508
  • Travere Therapeutics, Inc.$433
  • plus $2K from 11 others

What the payments were for

  • Consulting fees$10,21014%
  • Speaking & faculty fees$46,52562%
  • Travel & lodging$10,50014%
  • Food & beverage$7,63710%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,872 in reported general payments places this provider in the 95th percentile of 53 adult health providers in Utah.

See all adult health providers in Utah

Other adult health in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →